New Zealand City
| all links | finance | computing | entertainment | general | internet | sport | weather Return to NZCity
All Links
 
20 Jul 2025   
  
NZCity NewsLinks
Search 
TruScreen Group Limited SPP Update
TruScreen Group Limited (TruScreen or Company) (NZX: TRU, ASX: TRU) – Update on the Allocation of Share Purchase Plan (SPP) Shares 
© 2025 sharechat.co.nz Fri, 4 Jul 3:45pm 

TRU - TruScreen Preliminary Final Results
TruScreen generated product sales of $1.7m (2024: $2.1m) for the year. This lower result was largely due to delays in roll-out programs in Vietnam (launched April 2025), and Zimbabwe (delayed until FY2026) and delayed product registrations in Indonesia an 
© 2025 sharechat.co.nz Mon, 26 May 12:05am 

TruScreen Re-enters India Appinting New Distributor
TruScreen Group Limited (“TruScreen” or “the Company”) advises that it has re-entered the Indian sub-continent with the appointment of India medical products distributor Renovate Biologicals Pvt Ltd (RBL) 
© 2025 sharechat.co.nz Wed, 30 Apr 10:45am 

TruScreen to Present at Singapore Healthcare Day Forum
TruScreen Group Limited (“TruScreen” or “the Company”) advises that its CEO, Marty Dillon is an invited presenter at the Healthcare Day Forum held in Singapore on Monday March 24, 2025 
© 2025 sharechat.co.nz Mon, 24 Mar 1:05pm 

TRU - TruScreen Appoints Indonesian Distributor
TruScreen Group Limited (“TrusScreen” or “the Company”) advises the appointment of Indonesian medical products distributor PT Mawar Mitra Medika to distribute its unique AI enabled TruScreen cervical cancer screening system in Indo 
© 2025 sharechat.co.nz Wed, 29 Jan 4:05pm 

web advertising from webads, http://www.webads.co.nz

TRU - WHO Agency UNITAID Features TRU in Tech Landscape Report
TruScreen Group Limited (NZX/ASX:TRU) is pleased to announce that our TruScreen Ultra cervical cancer Screening device is included in the UNITAID “Screening and treatment of pre-cancerous lesions for secondary prevention of cervical cancer” te 
© 2025 sharechat.co.nz Thu, 3 Oct 10:25am 

Truscreen Commences Major Commercial Rollout in Vietnam
TruScreen Group Limited (NZX/ASX:TRU) is pleased to announce that its Vietnamese distributor GHS has ordered 10 TruScreen cervical cancer screening devices and 1,800 SUS, marking the commencement of their major commercial rollout of TruScreen in Vietnam 
© 2025 sharechat.co.nz Mon, 8 Jul 11:45am 

TRU - Preliminary Results for FY2024
Cervical cancer technology company Truscreen Group Limited (ASX/NZX: TRU) (the Company) has released its preliminary unaudited financial results for the year ended 31 March 2024 
© 2025 sharechat.co.nz Thu, 30 May 2:25pm 


web advertising from webads, http://www.webads.co.nz


TRU - Key Markets Update
TruScreen Group Limited (NZX/ASX: TRU), (“TruScreen” or “the Company”), a global leader in AI-enabled cervical cancer screening, is pleased to provide an update of its key and target markets 
© 2025 sharechat.co.nz Mon, 16 Jun 11:45am 

TRU - Published Saudi Arabia Study Confirms TruScreen's Results
TruScreen Group Limited (NZX/ASX:TRU) is pleased to share that the preliminary publication in July 2024 of a Saudi Arabia study investigating TruScreen’s performance versus pap smears in cervical cancer detection, has now been peer reviewed and publ 
© 2025 sharechat.co.nz Thu, 1 May 2:45pm 

web advertising from webads, http://www.webads.co.nz

TruScreen Signs MOU with Hangzhou Dalton Bioscience
TruScreen Group Limited has signed a non-binding Memorandum of Understanding (“MOU”) with Hangzhou Dalton Bioscience Limited (“DaltonBio”), a leading China based manufacturer of high-performance HPV DNA tests and laboratory equipme 
© 2025 sharechat.co.nz Thu, 27 Feb 11:45am 

TruScreen Invited to Present WHO AI Collaboration Meeting
At the invitation of World Health Organisation (WHO) TruScreen Group Limited (NZX/ASX:TRU) presented at a WHO global AI collaboration meeting on 11 and 12 November 2024 in Edinburgh. The meeting investigated the further use of Artificial Intelligence (AI) 
© 2025 sharechat.co.nz Mon, 13 Jan 11:25am 

TruScreen Markets Update
TruScreen Group Limited (NZX/ASX:TRU) is pleased to provide an update of its key markets and target markets 
© 2025 sharechat.co.nz Tue, 12 Nov 2:05pm 

Truscreen Test Outperforms Pap Smear in Saudi Arabia Study
TruScreen Cervical Cancer Screening Test Outperforms traditional Pap Smear in Saudi Arabia Study 
© 2025 sharechat.co.nz Mon, 5 Aug 11:25am 

web advertising from webads, http://www.webads.co.nz

TruScreen Group Limited ("TRU"ť) - Late Annual Report
NZ RegCo advises that TruScreen Group Limited (“TRU”) has not released its annual report for the year ending 31 March 2024 which, under NZX Listing Rule 3.6.1, was due to be released through MAP on or before Monday, 1 July 2024 
© 2025 sharechat.co.nz Tue, 2 Jul 11:25am 

©2025 New Zealand City, portions © 2025 sharechat.co.nz,
©2025 New Zealand City Ltd